Verge Genomics' ALS Drug Fails Amid Shift to Partner Model
Verge Genomics' only clinical-stage ALS drug has failed, prompting the company to shift its focus to a partnership model for its AI-driven discovery platform.
Tag
Als Drug
All articles tagged with #als drug
Amylyx to Remove ALS Drug Relyvrio from Market, Cut Staff by 70%
Amylyx Pharmaceuticals will remove its ALS drug Relyvrio from the market in the U.S. and Canada after a Phase 3 study involving 664 people failed to show a benefit. The decision will also lead to a 70% reduction in staff. Relyvrio had received FDA approval in 2022, but its efficacy was a subject of contention, with regulators initially advising against its approval until further testing was conducted.
BrainStorm's Workforce Reduction Paves Way for ALS Cell Therapy Market Push
BrainStorm Cell Therapeutics is laying off 30% of its staff as it reevaluates its trial design for its ALS drug, NurOwn, after withdrawing its Biologics License Application (BLA). The company aims to realign its resources for a new clinical trial following a refusal-to-file letter from the FDA and a 17-1 vote by an advisory committee stating that the drug did not demonstrate substantial evidence of effectiveness in a previous study.